Detalhe da pesquisa
1.
Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure.
Biopharm Drug Dispos
; 43(3): 98-107, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35405765
2.
Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.
Xenobiotica
; 48(9): 904-910, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29027832
3.
Altered xanthine oxidase and N-acetyltransferase activity in obese children.
Br J Clin Pharmacol
; 72(1): 109-15, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21382071
4.
Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology.
Clin Transl Sci
; 14(1): 395-404, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33073529
5.
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Clin Pharmacokinet
; 59(5): 617-627, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31713224